GlassScriptPhysician profile
Garvin Yee
NPI 1285616433
$4,979.30
in general payments reported to CMS, 2019-2025
21 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,421 · 2020: $1,544 · 2021: $797 · 2022: $620 · 2023: $318 · 2024: $127 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,557.87 | 2019-2022 | |
| Zyla Life Sciences, INC. | $1,348.59 | 2019-2020 | |
| Depuy Synthes Sales INC. | $665.30 | 2019-2025 | Orthovisc, Monovisc |
| Pacira Therapeutics, INC. | $305.20 | 2019-2021 | |
| Assertio Therapeutics, INC. | $165.15 | 2020 | |
| Vericel Corporation | $155.28 | 2019-2020 | |
| Bioventus LLC | $139.58 | 2021-2025 | Durolane, Xcell |
| Ferring Pharmaceuticals INC. | $116.00 | 2019-2023 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $106.14 | 2025 | Tapestry |
| Embody, INC. | $81.08 | 2023 | |
| Fidia Pharma USA INC. | $60.31 | 2019-2020 | |
| Ibsa Pharma INC. | $39.59 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $38.05 | 2024 | Zilretta, Iovera |
| Maruho Medical, INC. | $37.37 | 2020 | |
| Sanofi-Aventis U.S. LLC | $34.52 | 2022-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthogenrx INC. | $33.63 | 2020-2021 | |
| Forte Bio-Pharma LLC | $33.53 | 2024 | Prolate, Nalocet |
| Djo, LLC | $31.19 | 2020 | |
| Avanos Medical | $15.42 | 2023 | Grpro 2.1 |
| Smith+Nephew, INC. | $12.21 | 2019 | |
| Electronic Waveform Lab, INC. | $3.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garvin Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.